Genetics of coronary heart disease with reference to ApoAI-CIII-AIV gene region

Suraksha Agrawal1, Sarabjit Mastana1

  • 1Suraksha Agrawal, Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow UP 226014, India.

World Journal of Cardiology
|September 18, 2014
PubMed

Insights

Genetic factors significantly influence cardiovascular diseases, including coronary artery disease (CAD). This review explores the role of specific gene clusters, like ApoAI-CIII-AIV, in CAD susceptibility.

Area of Science:

  • Genetics and Molecular Biology
  • Cardiology
  • Population Health

Background:

  • Cardiovascular diseases (CVDs) result from complex interactions between genetic and environmental factors.
  • Twin and familial studies indicate a genetic predisposition to CVDs, with varying prevalence across ethnic groups.
  • Advancements in molecular techniques and genetic markers aid in understanding CVD physiology and identifying susceptibility genes.

Purpose of the Study:

  • To review the current understanding of genetic factors contributing to coronary artery disease (CAD) susceptibility.
  • To highlight the role of specific candidate genes and their pathways in CAD.
  • To discuss findings from genome-wide association studies (GWAS) identifying novel CAD-associated genes.

Main Methods:

  • Literature review of genetic studies on cardiovascular diseases and coronary artery disease.
  • Analysis of evidence from twin studies, familial aggregation, and ethnic population differences.
  • Examination of molecular markers and candidate gene studies.
  • Inclusion of findings from genome-wide association studies (GWAS).

Main Results:

  • Multiple genes contribute to CAD predisposition, but findings are often inconsistent.
  • Candidate gene studies suggest correlations with various CAD-related pathways.
  • GWAS have identified novel chromosomal locations and genes associated with CAD.
  • The ApoAI-CIII-AIV gene cluster is a focus of investigation for its role in CAD.

Conclusions:

  • Genetic susceptibility plays a crucial role in the development of cardiovascular diseases, particularly CAD.
  • Understanding the contribution of specific genes and gene clusters is essential for elucidating CAD etiology.
  • Further research is needed to reconcile inconsistent findings and validate novel genetic associations for CAD.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
113
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
134
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
186
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K